Description - Challenges and Opportunities in Using Residual Newborn Screening Samples for Translational Research by Roundtable on Translating Genomic-Based Research for Health
Newborn screening samples are used to test more than 4 million infants each year for life-threatening diseases that are treatable if found at birth. These specimens also represent a potentially invaluable resource for public health and biomedical research. The IOM held a workshop to examine issues surrounding the use of residual specimens for translational research.
Buy Challenges and Opportunities in Using Residual Newborn Screening Samples for Translational Research by Roundtable on Translating Genomic-Based Research for Health from Australia's Online Independent Bookstore, BooksDirect.
A Preview for this title is currently not available.